Replies to post #65757 on Biotech Values

[Biowatch]

INGN Red flags were in abundance when they filed the BLA on the basis of unproven biomarkers.

The more cynical question is why file, knowing they only had a sixty day window before a go/no go decision from the FDA?
--------------

The key to sound investment decisions is the ability to recognize the hurricane before the levee breaks.